Fujifilm opens unique cell culture facility
4 Oct 2013
Fujifilm Diosynth Biotechnologies has opened its mammalian cell culture cGMP manufacturing facility this week, the first of its kind in the UK.
The facility was purpose-built to utilise primarily single-use technologies for both upstream and downstream operations and is the latest in a series of laboratory investments made by Fujifilm.
Designed with input from regulatory authorities, the facility will offer high flexibility for meeting customers’ needs.
It has initially been commissioned with 200L and 1000L bioreactors, with a further 2000L bioreactor commissioned for 2014.
“This new capacity, using the latest single-use technologies, provides our customers with a full life-cycle offering for mammalian cell culture biopharmaceuticals from our UK site, and complements our offering in microbial-based biologics,” said managing director of Fujifilm Diosynth Biotechnologies UK Steve Bagshaw.
